Advances in allogeneic and autologous hematopoietic cell transplantation, cellular therapies, and immune-based approaches have always been driven by a close and dynamic interaction between basic science, translational research, and clinical innovation. The European Society for Blood and Marrow Transplantation (EBMT) has long been committed to fostering this continuum, recognizing that meaningful clinical progress depends on a deep understanding of underlying biological mechanisms. With this new series of publications in Bone Marrow Transplantation, the EBMT aims to further strengthen the bridge between fundamental discovery and clinical application. This initiative is designed to highlight cutting-edge research in immunology, stem cell biology, genomics, and cellular engineering, while placing these advances into a clear translational and clinical context relevant to the transplant and cellular therapy community. By bringing together leading scientists and clinician-scientists, this series seeks not only to disseminate knowledge, but also to stimulate collaboration, inspire innovation, and identify unmet needs that should shape future research priorities. Ultimately, our goal is to accelerate the translation of scientific insight into improved outcomes for patients undergoing transplantation and cellular therapies worldwide. Through this initiative, the EBMT and BMT journal reaffirm their commitment to scientific excellence, interdisciplinary dialogue, and the advancement of a truly integrated research ecosystem serving patients, researchers, and clinicians alike.

In this collection we highlight a selection of articles from 2025, which top the list of the journal’s most cited, downloaded and most shared (including press coverage, blogs, X, Facebook and Weibo). The articles showcase the breadth of scope and coverage that the journal consistently delivers to its readers.

EBMT research aims to further the knowledge base in haematopoietic stem cell transplantation and cell therapy with the ultimate goal of improving patient care. The EBMT coordinates its scientific activities through 11 Working Parties and the Nurses Group. This collection brings together EBMT publications in BMT.

This special issue of Bone Marrow Transplantation describes the impact of pre-transplant molecular measurable residual disease (MRD) on acute myeloid leukemia (AML) prognosis. The original pre-MEASURE study demonstrated the superior ability of error-corrected next generation sequencing (NGS), performed retrospectively on peripheral blood pre-transplant samples in a centralized setting, to predict post-transplant relapse and survival compared to flow cytometry in patients with FLT3-ITD or NPM1 mutated AML. The current collection of manuscripts presents additional original data describing the significance of FLT3-TKD, IDH1, and IDH2 persistence prior to transplantation. Review articles cover how pre-MEASURE has impacted clinical decision-making and the interpretation of NPM1 MRD throughout the treatment course of AML. Other manuscripts address the limitations of flow cytometric MRD assays in informing conditioning regimens, the role of the Center for International Blood and Marrow Transplant Research (CIBMTR) in precision transplantation investigation, and the importance of representation in clinical research. The ongoing, prospective multicenter MEASURE study will hopefully inform the most appropriate use of peri-transplant molecular MRD for AML.

In this collection we highlight a selection of articles from 2024, which top the list of the journal’s most cited, downloaded and most shared (including press coverage, blogs, Twitter, Facebook and Weibo). The articles showcase the breadth of scope and coverage that the journal consistently delivers to its readers.

In this collection we highlight a selection of articles from 2023, which top the list of the journal’s most cited, downloaded and most shared (including press coverage, blogs, Twitter, Facebook and Weibo). The articles showcase the breadth of scope and coverage that the journal consistently delivers to its readers.

Given the increasing importance of cellular therapies in the field of hematology, this collection showcases important papers - some published in BMT but also in other journals - with a short summary of the findings and a link to the original paper for those interested. The goal is to serve the community by collating papers of interest in this key area.

This Emerging Leaders collection welcomes and recognizes new talent in the hematology field. The collection acknowledges groundbreaking researchers, clinicians, and educators who are still in the early stages of their scientific careers, serving as a platform to showcase their work.

In this collection we highlight a selection of articles from 2022, which top the list of the journal’s most cited, downloaded and most shared (including press coverage, blogs, Twitter, Facebook and Weibo). The articles showcase the breadth of scope and coverage that the journal consistently delivers to its readers.